L-type Ca2+ channels activation and contraction elicited by myricetin on vascular smooth muscles

被引:36
作者
Fusi, F [1 ]
Saponara, S [1 ]
Frosini, M [1 ]
Gorelli, B [1 ]
Sgaragli, G [1 ]
机构
[1] Univ Siena, Dipartimento Sci Anat & Biomed, I-53100 Siena, Italy
关键词
(S)-(-)-Bay K 8644; myricetin; vascular smooth muscle; whole-cell patch-clamp; wine polyphenols;
D O I
10.1007/s00210-003-0836-y
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of myricetin (3,3',4',5,5',7-hesahydroxyflavone), a natural flavonoid found in edible plants, were studied on vascular smooth muscle L-type Ca2+ channels by comparing its mechanical, radioligand binding, and electrophysiological properties to those of the Ca2+ channel agonist (S)-(-)-Bay K 8644. In rat aorta rings, both myricetin and (S)-(-)-Bay K 8644 induced contractile responses, which were dependent upon prior exposure to K+. At 15 mM K+ (K15) the pEC(50) values for myricetin and (S)-(-)-Bay K 8644 were 4.43+/-0.03 and 7.92+/-0.13, respectively. Furthermore, the maximum tension response to myricetin was not significantly different from that elicited by either (S)-(-)-Bay K 8644 or K60. The Ca2+ channel blockers nifedipine, verapamil and diltiazem antagonised and fully reverted myricetin-, (S)-(-)-Bay K 8644- as well as K60-induced contractions. Both myricetin and (S)-(-)-Bay K 8644 potentiated rat aorta ring responses to K+, shifting the K+ concentration-response curve to the left. (S)-(-)-Bay K 8644, but not myricetin, inhibited in a concentration-dependent manner (+)-[H-3]PN200-110 binding in porcine aortic membranes. Electrophysiological recordings from single rat tail artery myocytes, under amphotericin B-perforated as well as conventional methods, showed that both myricetin and (S)-(-)-Bay K 8644 increased L-type Ba2+ current (I-Ba(L)) and shifted the maximum of the current-voltage relationship by 10 mV in the hyperpolarising direction, without, however, modifying the threshold potential. Furthermore, (S)-(-)-Bay K 8644 accelerated both activation and inactivation kinetics of I-Ba(L) while myricetin slowed down the activation kinetics. Finally, both (S)-(-)-Bay K 8644 and myricetin slowed down deactivation kinetics of I-Ba(L). These results suggest that myricetin induces vasoconstriction by activating L-type Ca2+ channel with similar efficacy but a site of action different to that of (S)-(-)-Bay K 8644.
引用
收藏
页码:470 / 478
页数:9
相关论文
共 24 条
[1]  
[Anonymous], 1985, GUIDE CARE USE LAB A
[2]  
BERGER ME, 1992, J PHARMACOL EXP THER, V263, P78
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[5]   VASODILATOR EFFECTS OF QUERCETIN IN ISOLATED RAT VASCULAR SMOOTH-MUSCLE [J].
DUARTE, J ;
PEREZVIZCAINO, F ;
ZARZUELO, A ;
JIMENEZ, J ;
TAMARGO, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 239 (1-3) :1-7
[6]   Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers [J].
Erlund, I ;
Kosonen, T ;
Alfthan, G ;
Mäenpää, J ;
Perttunen, K ;
Kenraali, J ;
Parantainen, J ;
Aro, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (08) :545-553
[7]   Effects of quercetin and rutin on vascular preparations - A comparison between mechanical and electrophysiological phenomena [J].
Fusi, F ;
Saponara, S ;
Pessina, F ;
Gorelli, B ;
Sgaragli, G .
EUROPEAN JOURNAL OF NUTRITION, 2003, 42 (01) :10-17
[8]   On the mechanisms of the antispasmodic action of some hindered phenols in rat aorta rings [J].
Fusi, F ;
Marazova, K ;
Pessina, F ;
Gorelli, B ;
Valoti, M ;
Frosini, M ;
Sgaragli, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 394 (01) :109-115
[9]   2,5-Di-t-butyl-1,4-benzohydroquinone (BHQ) inhibits vascular L-type Ca2+ channel via superoxide anion generation [J].
Fusi, F ;
Saponara, S ;
Gagov, H ;
Sgaragli, G .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 (07) :988-996
[10]   Pharmacokinetics and bioavailability of quercetin glycosides in humans [J].
Graefe, EU ;
Wittig, J ;
Mueller, S ;
Riethling, AK ;
Uehleke, B ;
Drewelow, B ;
Pforte, H ;
Jacobasch, G ;
Derendorf, H ;
Veit, M .
JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (05) :492-499